Theriva Biologics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $13.1M | $11.6M | $23.2M | $41.8M | $67.3M | $6.2M | $15.0M | $28.9M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $17.5M | $16.3M | $27.4M | $45.5M | $68.9M | $7.9M | $16.4M | $29.5M |
| Property, Plant & Equipment | $222.0K | $270.0K | $422.0K | $345.0K | $101.0K | $174.0K | $367.0K | $607.0K |
| Goodwill | — | $0 | $5.7M | $5.5M | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $19.6M | $17.4M | $19.8M | $19.2M | — | — | — | — |
| Total Assets | $38.2M | $35.4M | $55.2M | $71.9M | $70.4M | $8.4M | $17.2M | $30.1M |
| Liabilities | ||||||||
| Accounts Payable | $1.0M | $859.0K | $770.0K | $915.0K | $524.0K | $886.0K | $2.3M | $1.0M |
| Total Current Liabilities | $10.0M | $7.6M | $6.7M | $7.1M | $3.6M | $3.0M | $5.3M | $3.4M |
| Long-Term Debt | $1.7M | $92.0K | $162.0K | $221.0K | — | — | — | — |
| Total Liabilities | $22.9M | $16.3M | $15.5M | $17.3M | $5.0M | $3.2M | $5.7M | $3.7M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-358.7M | $-335.0M | $-309.3M | $-291.0M | $-271.3M | $-248.1M | $-235.5M | $-219.5M |
| Total Stockholders' Equity | $15.4M | $19.1M | $37.0M | $51.8M | $65.4M | $-4.8M | $1.8M | $17.1M |